Tanox. (TNOX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tanox. (TNOX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

From: tuck	4/12/2007 1:47:46 PM
	of 10

This is one dead board. TNOX to be munched by DNA soon for $20. Deal contains clause in which material risk to Xolair sales gives DNA an out. This might have happened given the recent label warning added. But Xolair nevertheless performed OK in the last 3 months. DNA's earnings PR, out yesterday, shows Xolair revenues increasing from $95 million in 1Q06 to $111 million in 1Q07, a 17% increase. This is, however, down sequentially from $117 million in 4Q06. The stock is off a bit despite the rally in the market, and the arbitrage spread is 6.7% with the stock at $18.75 and about a month to go till closing. I think that's good risk/reward, as I think the numbers we're seeing will not scuttle the deal. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext